Marshall Wace’s Biomerica BMRA Stock Holding History

Marshall Wace’s Portfolio BMRA Stock Details BMRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-20,655	Closed	-$902K	–	2667
2021 Q1	$902K	Buy	+20,655	New	+$1.06M	﹤0.01%	1713

Other funds holding BMRA

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HIMC

Heritage Investors Management Corp Bethesda, Maryland $3.61B AUM 35.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return

PCM

Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return

Marshall Wace's BMRA Position: Q2 2021 in Review

Marshall Wace sold out of Biomerica (BMRA) in Q2 2021, closing a stake of 20,655 shares — an estimated $902K sold.

Marshall Wace first reported a position in BMRA in Q1 2021 and held it in 1 quarter. The position peaked at $902K in Q1 2021. 26 funds tracked by Wall St. Rank hold BMRA as of Q2 2021.

Marshall Wace reported no remaining Biomerica position as of Q2 2021 after selling out during the quarter.
Marshall Wace sold 20,655 Biomerica shares in Q2 2021, an estimated $902K.
Marshall Wace first reported a position in Biomerica in Q1 2021 and held it in 1 quarter.
Marshall Wace's Biomerica position peaked at $902K in Q1 2021.
26 funds tracked by Wall St. Rank held Biomerica as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.